- Home
- / Intelligent Bio Solutions
Intelligent Bio Solutions
Stock Price
$0.2
2022-12-28
Market Capitalization
$7 M
2022-12-28
Revenue
$3.1 M
FY, 2025
Intelligent Bio Solutions Summary
Company Summary
- Overview
- GBS (formerly known as Glucose Biosensor Systems (Greater China) Holdings) is a biosensor diagnostic technology company. Its key product is Saliva Glucose Biosensor, a saliva glucose monitoring system for SARS-CoV-2 and diabetes management.
- Type
- Public
- Status
- Active
- HQ
- New York, NY, US | view all locations
- Website
- https://gbs.inc/
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
2 locations detected
New York, NY HQ
United States
142 W 57th St #9th
Barangaroo, NSW
Australia
l 35/100 Barangaroo Ave
Intelligent Bio Solutions Financials
Summary Financials
- Revenue (Q3, 2026)
- $1.1M
- Gross profit (Q3, 2026)
- $535.4K
- Net income (Q3, 2026)
- ($2.9M)
- Cash (Q3, 2026)
- $6.9M
- EBIT (Q3, 2026)
- ($2.9M)
- Enterprise value
- $2.0M